ATAI Life Sciences N.V. Files 8-K on Security Holder Vote

Ticker: ATAI · Form: 8-K · Filed: May 21, 2025 · CIK: 1840904

Atai Life Sciences N.V. 8-K Filing Summary
FieldDetail
CompanyAtai Life Sciences N.V. (ATAI)
Form Type8-K
Filed DateMay 21, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

ATAI Life Sciences N.V. is having a shareholder vote on May 15, 2025.

AI Summary

On May 15, 2025, ATAI Life Sciences N.V. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not specify the exact nature of the vote or any associated resolutions.

Why It Matters

This filing indicates that ATAI Life Sciences N.V. is engaging its shareholders on important corporate matters requiring a vote, which could impact the company's future direction.

Risk Assessment

Risk Level: low — The filing is a procedural notification of a shareholder vote and does not contain information about financial distress, significant operational changes, or regulatory actions.

Key Players & Entities

  • ATAI Life Sciences N.V. (company) — Registrant
  • May 15, 2025 (date) — Date of earliest event reported
  • Wallstraße 16, 10179 Berlin, Germany (address) — Principal executive offices

FAQ

What specific matters are being submitted for a vote by ATAI Life Sciences N.V. security holders?

The filing does not specify the exact matters being submitted for a vote; it only states that a submission of matters to a vote of security holders has occurred.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 15, 2025.

What is the principal executive office address for ATAI Life Sciences N.V.?

The principal executive office address for ATAI Life Sciences N.V. is Wallstraße 16, 10179 Berlin, Germany.

Under which section of the Securities Exchange Act of 1934 is this 8-K filed?

This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the Commission File Number for ATAI Life Sciences N.V.?

The Commission File Number for ATAI Life Sciences N.V. is 001-40493.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding ATAI Life Sciences N.V. (ATAI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.